Chinese english Germany Japanese Korea

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile Struktur
342780-45-4
CAS-Nr.
342780-45-4
Englisch Name:
2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
Synonyma:
2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile;4H-1-Benzopyran-3-carbonitrile, 2-amino-4-[4-(difluoromethoxy)phenyl]-5,6,7,8-tetrahydro-7,7-dimethyl-5-oxo-
CBNumber:
CB01941065
Summenformel:
C19H18F2N2O3
Molgewicht:
360.35
MOL-Datei:
342780-45-4.mol
Request For Quotation

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile Eigenschaften

Siedepunkt:
555.4±50.0 °C(Predicted)
Dichte
1.33±0.1 g/cm3(Predicted)
pka
3.25±0.60(Predicted)

Sicherheit

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile Chemische Eigenschaften,Einsatz,Produktion Methoden

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
VITAS-M LABORATORY, LTD. --
 Russia 6754 64
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Specs --
 info@specs.net The Netherlands 6835 70
  • 2-amino-4-[4-(difluoromethoxy)phenyl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
  • 4H-1-Benzopyran-3-carbonitrile, 2-amino-4-[4-(difluoromethoxy)phenyl]-5,6,7,8-tetrahydro-7,7-dimethyl-5-oxo-
  • 342780-45-4
  • C19H18F2N2O3
Copyright 2019 © ChemicalBook. All rights reserved